FTC marks revived ‘prior approval’ merger stance with proposed limits on DaVita

FTC

The Federal Trade Commission proposed 10-year acquisition restrictions on dialysis service provider DaVita under the agency’s newly reinstated “prior approval” policy aimed at curbing anticompetitive mergers.

This is Members-only content
To continue reading, choose one of the options below: